The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Morgan Stanley Downgrades Rolls-Royce

Wed, 27th Nov 2019 09:27

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

----------

FTSE 100

----------

MORGAN STANLEY CUTS ROLLS-ROYCE TO 'EQUAL-WEIGHT' (OVERWEIGHT) - PRICE TARGET 800 (925) PENCE

----------

BARCLAYS CUTS JOHNSON MATTHEY TARGET TO 3330 (3790) PENCE - 'EQUAL WEIGHT'

----------

LIBERUM CUTS JOHNSON MATTHEY PRICE TARGET TO 3500 (4400) PENCE - 'BUY'

----------

LIBERUM RAISES ASTRAZENECA PRICE TARGET TO 8300 (8250) PENCE - 'BUY'

----------

UBS RAISES CRH PRICE TARGET TO 3300 (2950) PENCE - 'BUY'

----------

DZ BANK RAISES FAIR VALUE FOR CRH TO 38.50 (35.00) EUR - 'BUY'

----------

CREDIT SUISSE RAISES CRH PRICE TARGET TO 38 (32) EUR - 'NEUTRAL'

----------

RBC CUTS COMPASS GROUP PRICE TARGET TO 1800 (1850) PENCE - 'SECTOR PERFORM'

----------

JPMORGAN CUTS COMPASS GROUP PRICE TARGET TO 2040 (2100) PENCE - 'OVERWEIGHT'

----------

GOLDMAN RAISES BURBERRY PRICE TARGET TO 2200 (2177) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS GLENCORE PRICE TARGET TO 242 (245) PENCE - 'NEUTRAL'

----------

CREDIT SUISSE RAISES COCA-COLA HBC TARGET TO 3050 (3000) PENCE - 'OUTPERFORM'

----------

JEFFERIES RAISES INTERTEK PRICE TARGET TO 6300 (6100) PENCE - 'BUY'

----------

FTSE 250

----------

CITIGROUP CUTS PENNON GROUP TO 'NEUTRAL' ('BUY') - TARGET 950 PENCE

----------

HSBC RAISES PENNON GROUP PRICE TARGET TO 980 (950) PENCE - 'BUY'

----------

BERENBERG CUTS MITCHELLS & BUTLERS TO 'HOLD' ('BUY') - TARGET 480 (360) PENCE

----------

HSBC RAISES TALK TALK TELECOM PRICE TARGET TO 95 (82) PENCE - 'REDUCE'

----------

BARCLAYS CUTS VICTREX PRICE TARGET TO 1940 (2020) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS CUTS COATS GROUP PRICE TARGET TO 76 (82) PENCE - 'EQUAL WEIGHT'

----------

LIBERUM CUTS ROYAL MAIL PRICE TARGET TO 175 (185) PENCE - 'SELL'

----------

JEFFERIES RAISES SOFTCAT PRICE TARGET TO 1300 (1250) PENCE - 'BUY'

----------

HSBC CUTS NEWRIVER PRICE TARGET TO 232 (244) PENCE - 'BUY'

----------

HSBC CUTS HAMMERSON PRICE TARGET TO 356 (400) PENCE - 'BUY'

----------

HSBC CUTS CAPITAL & COUNTIES TO 'HOLD' ('BUY') - TARGET 265 (301) PENCE

----------

JEFFERIES CUTS SHAFTESBURY TO 'UNDERPERFORM' ('HOLD') - TARGET 790 PENCE

----------

HSBC CUTS EQUINITI PRICE TARGET TO 280 (295) PENCE - 'BUY'

----------

HSBC RAISES CRANSWICK PRICE TARGET TO 3000 (2780) PENCE - 'HOLD'

----------

RBC INITIATES BIG YELLOW GROUP WITH 'UNDERPERFORM' - TARGET 975 PENCE

----------

JPMORGAN CUTS WILLIAM HILL PRICE TARGET TO 170 (180) PENCE - 'NEUTRAL'

----------

BARCLAYS CUTS WILLIAM HILL PRICE TARGET TO 215 (226) PENCE - 'OVERWEIGHT'

----------

OTHER MAIN MARKET AND AIM

----------

HSBC CUTS INTU PROPERTIES PRICE TARGET TO 36 (40) PENCE - 'REDUCE'

----------

HSBC RAISES STOBART GROUP PRICE TARGET TO 129 (124) PENCE - 'HOLD'

----------

JEFFERIES RAISES OXFORD INSTRUMENTS PRICE TARGET TO 1530 (1070) PENCE - 'HOLD'

----------

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.